This is a non-core endpoint: only basic statistics are computed.
Lipodystrophy, not elsewhere classified
DOID EFO MESH SNOMED Endpoint Browser
E4_LIPODYST
lipodystrophy: a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Greek for "fat", and "dystrophy" is Greek for "abnormal or degenerative condition".)
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
E88.1#
Hospital discharge: ICD-9
2726
Cause of death: ICD-10
E88.1#
Cause of death: ICD-9
2726
2 out of 7 registries used, show all original rules.
41
Check minimum number of events None
41
Include endpoints None
41
Remove individuals based on genotype QC
40
E4_LIPODYST
Control definitions
Control exclude
E4_METABOLIA
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E88
Name in latin
Lipodystrophia non alibi classificata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Lipodystrophy, not elsewhere classified
based on the number of shared cases.
Broader endpoints:
- Other metabolic disorders
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 40 | 33 | 7 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.00 |
| Mean age at first event (years) | 46.40 | 45.32 | 51.46 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_LIPODYST – Lipodystrophy, not elsewhere classified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Lipodystrophy, not elsewhere classified
↥Endpoint not on priority list, no data to show.